Events & Training for May 2017

5th International Conference on Bio–Sensing Technology

07 May 2017 - 10 May 2017

Bio-sensing technologies are of increasing importance in healthcare, agri-food, environmental and security sectors, and this is reflected in the continued growth of global markets for such technologies. This conference will provide a forum for accessing the most up-to-date and authoritative knowledge from both commercial and academic worlds, sharing best practice in the field as well as learning about case studies of successfully integrated bio-sensing technologies. The meeting will provide an opportunity to highlight recent developments and to identify emerging and future areas of growth in this exciting field.

Riva Del Garda Congress Centre, Lake Garda, Italy

Pharmaceutical Freeze Drying Technology

08 May 2017 - 09 May 2017

SMi are delighted to announce that a brochure has been released for Pharmaceutical Freeze Drying 2017! Robust capabilities in lyophilisation and freeze drying methods have become critical for process efficiency and commercial success whilst maintaining product quality and biological stability. Innovation and efficiency is requested at every level making Pharmaceutical Freeze Drying Technology the perfect platform to strengthen knowledge in key principles such as PAT and QbD, whilst staying at the forefront of technological breakthroughs to adapt to growing manufacturing demands. Gathering a room of Senior Scientists and Heads of Pharmaceutical Engineering, the 5th annual show provides an ideal forum to discuss the latest advancements in pharmaceutical lyophilisation, welcoming regulatory guidance from the NIBSC-MHRA and expertise from the likes of Sanofi, Boehringer Ingelheim, Roche, Novo Nordisk and more! FEATURED SPEAKERS: • Bakul Bhatnagar, Senior Principal Scientist Bio Therapeutics R&D, Pfizer • Sune Klint Andersen, Principal Scientist, Novo Nordisk • Jean-René Authelin, Global Head of Pharmaceutical, Engineering, Sanofi • Pierre Goldbach, Pharmaceutical Development and Supplies, Roche • Paul Matejtschuk, Principle Scientist, NIBSC - MHRA • Mahammad Ahmed, Associate Scientist II, Medimmune • Patrick Garidel, Head of Pharmaceutical Basic Development, Boehringer Ingelheim • Christoph Korpus, Laboratory Head, Merck • Xiaodong Chen, Senior Research Investigator, Bristol-Myers Squibb REASONS TO ATTEND: • Sanofi , Pfizer and GSK discuss the key to securing successful scale-up in lyophilisation • Hear about innovations in freeze drying processes and technology • Tackle challenges in freeze-drying high concentration biologics • An update on collapsed freeze drying and spray drying as alternative approaches to conventional batch freeze drying • New approaches to PAT and QbD principles • Exciting insight into current and future developments in continuous manufacturing For more information visit or contact the team on +44 (0)20 7827 6000 / Email:

Copthorne Tara Hotel, Kensington, London UK

Orphan Drugs and Rare Diseases Europe 2017

15 May 2017 - 16 May 2017

SMi is proud to announce the return of their 6th annual Orphan Drugs event to Berlin on the 15th -16th May 2017! The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019.* With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market. Germany is Europe's largest pharma market but is recognised as having one of the toughest pricing policies in Europe. SMi’s 6th annual Orphan Drugs will discuss the controversial German pricing mechanism as well as bring together leading industry professionals to discuss the latest regulatory developments, explore how to reduce costs and learn from the latest innovations in the orphan drug landscape.

Crowne Plaza, Potsdamer Platz, Berlin, Germany

11th Pharmaceutical Logistics

18 May 2017 - 19 May 2017

As outsourcing logistical tasks continues to be an emerging lucrative trend within the pharma industry, SMi Group proudly announces the return of its 11th annual Pharmaceutical Logistics event to London on 18-19th May 2017. The two-day event will bring together leading movers and shakers within the pharmaceutical supply chain to discuss the latest regulatory developments, explore cost reduction and hear about developments in effective temperature regulation and transit security. Join us as we consider logistical challenges in emerging markets, examine new innovations and discover best practices for all stakeholders. Early Bird rates available.

Copthorne Tara Hotel, Kensington, London UK

Highly Potent Active Pharmaceutical Ingredients 2017

22 May 2017 - 23 May 2017

The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs. However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions. This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find innovative new solutions

Copthrone Tara Hotel, Scarsdale Place, Kensington, London, UK

Pain Therapeutics 2017

22 May 2017 - 23 May 2017

Created with an expert scientific advisory board, SMi’s 17th annual Pain Therapeutics conference will hone in on the latest innovations and novel approaches to pain therapy and analgesic drugs as well as look at the practicalities of using animal models and translational biomarkers in pain research. Aimed at an audience of scientific leaders and senior specialists in neuroscience, CNS, clinical operations and pharmacology, Pain Therapeutics 2017 will keep attendees at the forefront of medical breakthroughs to adapt to the growing need towards minimising opioid dependency and new drug discovery. Presentations from a selection of hand-picked pharmaceutical companies currently developing novel treatments in pain, will provide delegates with an understanding on key topics such as product formulation; opioid addiction; translational pain research; and breakthroughs in drug discovery. Interactive workshops and exclusive new findings from phase II clinical trials will be just some of the highlights at the 17th annual show when it returns to London this spring. KEYNOTE SPEAKERS INCLUDE: • Prof Anthony Jones, Professor of Neuro-Rheumatology, University of Manchester • Dr Steven Kamerling, Therapeutic Area Head for Pain, Inflammation and Oncology, Zoetis • Dr Joseph W. Stauffer, Chief Medical Officer, Cara Therapeutics Inc • Dr Stephen Doberstein, Senior Vice President and Chief Scientific Officer, Nektar Pharmaceuticals • Dr Iain Chessell, Head of Neuroscience, AstraZeneca • Dr Randall Stevens, Chief Medical Officer, Centrexion Therapeutics Corp • Dr Richard Butt, Chief Executive Officer, Apollo Therapeutics • Prof Theo Meert, Head of Global Government Grant Office, Janssen Pharmaceutica NV • Dr Narender Gavva, Scientific Director, Amgen • Dr Thomas Christoph, Head of Pharmacology and Biomarker Development, Grunenthal GmbH • Dr Ian Bell, Principal Scientist, MSD, USA The packed agenda also features talks from Lilly UK, Novartis, Pharmaleads, Mundipharma Research and more! REASONS TO ATTEND IN 2017 • Awareness of new guideline on the clinical development of medicinal products intended for the treatment of pain • Strategies and real case studies to minimise risk of opioid dependence • Evaluate the translation gap with case studies from a pre-clinical and clinical perspective • Explore the latest in the area of Neuropathic pain for 2017 with the latest case studies from top pharma companies • Examine the use of animal models to study pain pathways Visit the website for further details at or contact the team on +44 (0)20 7827 6000 / email:

Copthorne Tara Hotel, Kensington, London UK